Jubilant Ingrevia Limited (JUBLINGREA.NS) Bundle
Jubilant Ingrevia Limited stands at the intersection of chemistry and commerce-serving more than 1,500 global clients across over 50 countries with cGMP-, REACH-, US FDA- and ISO-compliant facilities and a portfolio spanning pharmaceuticals, nutrition, agrochemicals, personal care and performance materials; the demerged specialist reported a revenue of ₹4,178 crore in FY 2025 (up from ₹4,136 crore), delivered a profit after tax of ₹251 crore-a 37% year‑on‑year increase-and EPS of ₹15.9, reflecting how its mission to drive innovation, cost-effective solutions and environmental stewardship, together with a vision to be a top-ten employer in India and core values like "Inspire Confidence," "Always Stretch," "Excellent Quality" and "Nurture Innovation," translate into measurable commercial and operational momentum that shapes its role as a trusted partner to Fortune 500 innovators-read on to explore how these strategic pillars steer growth, governance and sustainability across its global value chains.
Jubilant Ingrevia Limited (JUBLINGREA.NS) - Intro
Jubilant Ingrevia Limited is a globally integrated life sciences and specialty chemicals company that provides high-performance solutions across pharmaceuticals, nutrition, agrochemicals, personal care, industrial chemicals, and performance materials. Born from a demerger of Jubilant Life Sciences, the company leverages deep chemistry capabilities, regulatory expertise, and customer-focused innovation to serve complex global value chains.- Global footprint: presence in over 50 countries with a customer base of more than 1,500 clients, including multiple global innovators and Fortune 500 companies.
- Regulatory and quality compliance: facilities aligned to cGMP, REACH, US FDA norms and certified to applicable ISO standards.
- R&D and talent: teams of qualified scientists and technologists focused on proprietary molecules, custom synthesis, and green chemistry initiatives.
| Metric | FY 2024 | FY 2025 |
|---|---|---|
| Revenue (₹ crore) | 4,136 | 4,178 |
| Profit After Tax (₹ crore) | 184 | 251 |
| Earnings Per Share (₹) | 11.6 | 15.9 |
| Specialty Chemicals Volume Growth | - | Double-digit |
| Global Presence | 50+ countries | 50+ countries |
| Customer Base | ~1,500 clients | ~1,500 clients |
- Deliver sustainable, high-quality chemical and life-science solutions that enable customers to innovate and scale safely and efficiently.
- Create value for stakeholders through continuous operational excellence, regulatory compliance, and market-relevant R&D.
- Champion environmentally responsible manufacturing and green chemistry to reduce lifecycle impact.
- Be a preferred global partner for differentiated specialty chemicals and life-science ingredients, recognized for technical reliability, supply-chain agility, and innovation.
- Expand value chain reach across pharma, nutrition, agro, and performance materials while driving margin-accretive growth.
- Customer Centricity - align R&D, quality, and supply to deliver dependable outcomes for innovators and large enterprises.
- Integrity & Compliance - adhere to stringent regulatory norms and ethical business conduct across geographies.
- Innovation & Excellence - invest in proprietary chemistry, process optimization, and scalable technologies.
- Safety & Sustainability - prioritize occupational safety, product stewardship, and green-process adoption.
- Collaboration & Respect - foster cross-functional teamwork and partnerships with customers and academia.
- Portfolio diversification: grow higher-margin specialty chemicals and value-added intermediates while retaining core custom synthesis services.
- Operational rigour: optimize manufacturing throughput and yield, leveraging cGMP and process controls to support global supply reliability.
- R&D pipeline: accelerate proprietary molecules and green chemistry projects to capture differentiated opportunities.
- Customer partnerships: deepen relationships with the 1,500+ client base, including Fortune 500 innovators, to secure long-term contracts and integrated solutions.
- Multisite certifications (cGMP, REACH, US FDA, ISO) ensure market access and regulatory robustness across geographies.
- Supply-chain resilience initiatives, including diversified sourcing and inventory strategies, support consistent deliveries during demand shocks.
- Environmental and safety programs target reduction in emissions, waste, and occupational incidents as part of ESG commitments.
Jubilant Ingrevia Limited (JUBLINGREA.NS) - Overview
Jubilant Ingrevia Limited's mission centers on creating sustained stakeholder value through innovation, cost efficiency and responsible operations. The company integrates commercial objectives with environmental stewardship and social responsibility to deliver differentiated chemical and life‑science solutions.- Deliver innovative, high‑value products and economically efficient solutions to customers.
- Drive shareholder value via sales growth, margin improvement, and disciplined capital allocation.
- Operate with utmost care for the environment, embedding sustainable practices across manufacturing and supply chains.
- Balance growth ambitions with social responsibility and long‑term value creation.
- R&D-led product development for specialty chemicals, nutrition, and life‑science intermediates.
- Operational excellence and cost optimization across global manufacturing footprint.
- Decarbonization, waste reduction and regulatory compliance to minimize environmental impact.
- Market diversification and increased share of higher‑margin specialty segments.
| Metric | Value (INR crore) | Notes / Year |
|---|---|---|
| Revenue (Total Income) | 4,892 | FY2023 (consolidated) - sales across specialty chemicals, nutrition, and life‑science intermediates |
| EBITDA | 881 | FY2023 - reflects margin from specialty portfolio |
| Profit After Tax (PAT) | 427 | FY2023 - consolidated |
| Net Debt | 1,200 | Approx. end‑FY2023 - focus on deleveraging program |
| Exports / Overseas Sales | ~60% | Share of revenue from international markets, FY2023 |
| R&D Spend | ~1.2% of Revenue | Ongoing investment to support specialty product pipeline |
- Innovation: Persistent investment in formulation and process technologies to move up the value chain.
- Integrity: Compliance, safety and transparent governance across reporting and operations.
- Sustainability: Emission controls, wastewater treatment, energy optimization and circularity initiatives.
- Customer Centricity: Tailored solutions, quality assurance and global technical support networks.
- Employee Empowerment: Skill development, safety culture and diversity initiatives to sustain human capital.
- Product portfolio shift toward higher‑margin specialties and nutraceutical intermediates to improve EBITDA profile.
- Capital allocation focused on capacity expansion where technology differentiation yields stronger returns.
- Sustainability targets tied to reduced specific energy use, lower water intensity and incremental renewable energy adoption.
- Performance metrics aligned to mission: revenue growth, margin improvement, return on capital employed (ROCE) and reduction in specific emissions.
Jubilant Ingrevia Limited (JUBLINGREA.NS) - Mission Statement
Jubilant Ingrevia Limited positions its mission around creating sustainable stakeholder value through innovation, operational excellence, and an inclusive workplace that treats talent purely on merit. The company's mission translates its vision into measurable commitments across people, processes, products, safety, environment and returns.- Respect for individual rights and equal opportunity employment irrespective of nationality, race, caste, creed, religion or gender.
- Foster creativity, decentralized decision-making and empowerment at all levels to drive agility and responsiveness.
- Deliver cost-effective, efficient operations with flawless execution to maximize value for customers, shareholders and partners.
- Prioritize environmental stewardship, process safety and product quality as non-negotiable foundations.
- Embed continuous learning and knowledge-sharing to spur market-led innovation and surprise stakeholders with differentiated solutions.
Quantitative Manifestation of the Mission (Selected KPIs and Targets)
| Metric | Latest Reported / Baseline | Near-term Target |
|---|---|---|
| Revenue (FY) | ₹3,900 crore (approx., latest fiscal) | Grow to ₹5,000 crore in 3 years |
| Net Profit (PAT) | ₹230 crore (approx.) | Improve PAT margin by 200-300 bps |
| Employee strength | ~3,500 employees | Top-10 employer in India target; 20% growth in talent base with diversity hires |
| Manufacturing sites | 8 major facilities (India & global partnerships) | Capacity expansion across specialties to support export growth |
| Exports share | ~60% of revenue | Increase to 65-70% |
| R&D spend | ~2.2% of revenue | Raise to 3%+ with focused innovation programs |
| Safety & EHS | Recordable incident rate improving year-on-year; multiple ISO/OHSAS certifications | Zero major incidents; continuous improvement in environmental KPIs |
| Carbon / Emissions target | Baseline established; efficiency programs underway | Reduce CO2 intensity by 25% by 2030 |
- People & Culture metrics: diversity ratio targets, internal promotion rates, leadership development coverage and employee engagement scores drive the "top-10 employer" ambition.
- Operational metrics: Overall Equipment Effectiveness (OEE), on-time delivery >95%, and cost-per-unit improvement form the backbone of the cost-effectiveness pledge.
- Innovation metrics: percentage of revenue from new products (targeting rising contribution year-on-year), patent filings and cross-market collaborations.
How the Vision Informs Daily Decisions and Investor-Relevant Outcomes
- Talent decisions: meritocratic hiring and promotion with structured bias-mitigation processes to uphold equal opportunity.
- Operational investments: capex allocations prioritize flexible, scalable lines that improve cycle times and reduce per-unit cost.
- Sustainability investments: process upgrades, solvent recovery, waste-minimization projects and safety systems to reduce environmental footprint and regulatory risk.
- Market strategy: focus on higher value-added chemistries, specialty ingredients and custom solutions to improve margins and deepen customer relationships.
Jubilant Ingrevia Limited (JUBLINGREA.NS): Vision Statement
Jubilant Ingrevia Limited's vision is to be a global leader in specialty chemicals and nutraceuticals - delivering sustainable, innovative, and high-quality solutions that create superior value for customers, shareholders, employees, and society. The vision drives strategic investments in technology, scale-up of global manufacturing, and expansion into higher-margin, specialty segments while upholding safety and environmental stewardship.- Global leadership in specialty ingredients and life‑science solutions through focused R&D and customer collaboration.
- Consistent delivery of sustainable growth and margin improvement by moving up the value chain.
- Embedding safety, environmental care, and community responsibility across all operations.
- Inspire Confidence: Carefully selecting, training, and developing people to be creative and empowering them to take decisions so they respond to all stakeholders with agility, confidence, and teamwork.
- Always Stretch: Striving to be cost‑effective and efficient in all aspects of operations, focusing on flawless delivery to create and provide the best value to stakeholders.
- Excellent Quality: With utmost care for the environment and safety, always striving to excel in the quality of processes, products, and services.
- Nurture Innovation: Sharing knowledge and learning from each other and from markets served, continuing to surprise stakeholders with innovative solutions.
| Metric | Latest Reported/Fiscal | Notes |
|---|---|---|
| Revenue (Consolidated) | ₹2,800-3,000 crore (FY) | Driven by specialty chemicals, nutrition & pharma intermediates |
| EBITDA | ~₹500-600 crore (FY) | Focused margin improvement via specialty mix & efficiencies |
| PAT | ~₹200-300 crore (FY) | Subject to product mix and raw material cycles |
| Market Capitalization | ₹8,000-9,000 crore (approx.) | Reflects investor view on specialty transition and growth |
| Manufacturing Sites | 8-10 global sites | Multiple plants across India with global outreach |
| Employees | ~3,500-4,000 | Skilled workforce across R&D, manufacturing, and commercial |
| R&D Centers | 3-4 | Focus on process development, formulation & application labs |
| Export Contribution | 40-55% of sales | Strong global customer base in specialty markets |
- Talent & Culture: Structured training, leadership programs, and decentralised decision rights to Inspire Confidence and enable faster customer response.
- Operational Excellence: Continuous improvement projects, CAPEX for debottlenecking, and cost initiatives to Always Stretch and improve margins.
- Quality & Safety: ISO and industry certifications, environment & safety investments ensuring Excellent Quality and compliance across sites.
- Innovation Pipeline: Cross‑functional product teams and market‑driven R&D to Nurture Innovation and launch differentiated specialties.

Jubilant Ingrevia Limited (JUBLINGREA.NS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.